Clinical and acoustical variability in hypokinetic dysarthria.

Ten male patients with parkinsonism secondary to Parkinson's disease or progressive supranuclear palsy had clinical neurological, speech, and acoustical speech evaluations. In addition, seven of the patients were evaluated by x-ray computed tomography (CT) and (F-18)-fluorodeoxyglucose (FDG) positron emission tomography (PET). Extensive variability of speech features, both clinical and acoustical, were found and seemed to be independent of the severity of any parkinsonian sign, CT, or FDG PET. In addition, little relationship existed between the variability across each measured speech feature. What appeared to be important for the appearance of abnormal acoustic measures was the degree of overall severity of the dysarthria. These observations suggest that a better understanding of hypokinetic dysarthria may result from more extensive examination of the variability between patients. Emphasizing a specific feature such as rapid speaking rate in characterizing hypokinetic dysarthria focuses on a single and inconstant finding in a complex speech pattern.

[1]  L. Squire,et al.  Comparison of metabolic rates, language, and memory in subcortical aphasias , 1983, Brain and Language.

[2]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[3]  M E Phelps,et al.  ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J. Logemann,et al.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. , 1978, The Journal of speech and hearing disorders.

[5]  A. Aronson,et al.  Motor Speech Disorders , 2014 .

[6]  Raymond D. Kent,et al.  Prosodic disturbance and neurologic lesion , 1982, Brain and Language.

[7]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .

[8]  David E. Kuhl,et al.  Journal of Cerebral Blood Flow and Metabolism Cerebral Metabolic Relationships for Selected Brain Regions in Alzheimer's, Huntington's, and Parkinson's Diseases , 2022 .

[9]  Michael E. Phelps,et al.  Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  W. Hanson DAF speech rate modification in Parkinson's disease : A report of two cases , 1983 .

[11]  E. J. Kreul Neuromuscular control examination (NMC) for Parkinsonism: vowel prolongations and diadochokinetic and reading rates. , 1972, Journal of speech and hearing research.

[12]  G. Canter SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE. 3. ARTICULATION, DIADOCHOKINESIS, AND OVER-ALL SPEECH ADEQUACY. , 1965, The Journal of speech and hearing disorders.

[13]  M E Phelps,et al.  18FDG positron emission computed tomography in a study of aphasia , 1981, Annals of neurology.

[14]  C. Miller,et al.  Motor nuclear involvement in progressive supranuclear palsy. , 1969, Archives of neurology.

[15]  G. Canter SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE: I. INTENSITY, PITCH, AND DURATION. , 1963, The Journal of speech and hearing disorders.

[16]  S. Ringel,et al.  Observations on the efficacy of L-dopa in progressive supranuclear palsy. , 1971, European neurology.

[17]  J. Abbs,et al.  The relationship between parkinsonian rigidity and hypokinesia in the orofacial system , 1982, Neurology.

[18]  E. J. Metter,et al.  DAF as instrumental treatment for dysarthria in progressive supranuclear palsy: a case report. , 1980, The Journal of speech and hearing disorders.

[19]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[20]  W. Matthews,et al.  Progressive supranuclear palsy. Clinico-pathological study of four cases. , 1969, Brain : a journal of neurology.

[21]  E. Yeterian,et al.  Cortico-striate projections in the rhesus monkey: The organization of certain cortico-caudate connections , 1978, Brain Research.

[22]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.